Ingenes

Ingenes is a leading assisted reproduction institute specializing in fertility and genetics solutions, established in 2005. The company holds the largest market share in Mexico for resolving highly complex fertility cases, leveraging extensive experience and a track record of over a thousand successful births. Ingenes's success rates in in vitro fertilization (IVF) using a patient's own eggs significantly surpass industry averages, reporting 78 percent above the RedLara accredited fertility centers and 10 percent above United States clinics. This performance underscores their commitment to achieving pregnancies with minimal physical, emotional, and economic stress for patients.

Operating with a team of 500 - 1,000 employees across 4 locations, Ingenes focuses on delivering integral reproductive health treatments. The institute is recognized as a dedicated genetics and fertility research entity by Mexico's National Science and Technology Council (CONACYT). Its research and clinical practices are also acknowledged by international bodies such as the Latin America Network of Assisted Reproduction (RedLara) and Fertility Centers of Illinois, highlighting its global standing. Meet Ingenes's team to understand the expertise driving these advanced reproductive services.

Ingenes's product portfolio encompasses fertility treatments, genetic analysis, and comprehensive reproductive health services, including specialized techniques like microarray. The company's mission is to ensure that the vast majority of its patients can successfully conceive and bring a baby home. Their advanced methodologies and patient-centric approach position them as a premier provider in the assisted reproduction sector, consistently aiming for superior outcomes in a complex medical field.